Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$1,186,120
-$1,277,177 QoQ
Shares Held
81,971
-64.6% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Derivatives in DSGN

reported options exposure · as of Jun 30, 2026
CallValue
$201,133
CallShares
13,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. DSGN ranks #222 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in DSGN

Export CSV
45 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $201,133 13,900
2026-06-30 $1,186,120 81,971
2026-03-31 $2,463,297 231,513
2025-12-31 $4,313,618 459,874
2025-09-30 $4,171,770 554,020
2025-06-30 $2,833,472 840,793
2025-03-31 $3,718,955 963,460
2025-03-31 $11,966 3,100
2025-03-31 $15,440 4,000
2024-12-31 $16,042 2,600
2024-12-31 $5,915,752 958,793
2024-12-31 $28,382 4,600
2024-09-30 $12,374 2,300
2024-09-30 $3,096,459 575,550
2024-09-30 $14,526 2,700
2024-06-30 $1,020,509 304,630
2024-06-30 $23,450 7,000
2024-06-30 $3,685 1,100
2024-03-31 $3,525,351 874,777
2024-03-31 $403 100
2024-03-31 $403 100
2023-12-31 $7,950 3,000
2023-12-31 $4,855,472 1,832,254
2023-12-31 $6,890 2,600
2023-09-30 $6,373,304 2,700,553
2023-09-30 $8,732 3,700
2023-09-30 $17,228 7,300
2023-06-30 $7,560 1,200
2023-06-30 $26,460 4,200
2023-06-30 $17,993,467 2,856,106
2023-03-31 $35,197 6,100
2023-03-31 $49,622 8,600
2023-03-31 $16,532,013 2,865,167
2022-12-31 $119,016 11,600
2022-12-31 $25,676,275 2,502,561
2022-12-31 $1,699,056 165,600
2022-09-30 $40,491,358 2,421,732
2022-09-30 $2,661,824 159,200
2022-06-30 $1,850,800 132,200
2022-06-30 $35,639,212 2,545,658
2022-03-31 $40,935,437 2,534,702
2021-12-31 $54,267,969 2,534,702
2021-09-30 $37,790,465 2,572,530
2021-06-30 $51,040,682 2,566,148
2021-03-31 $75,787,619 2,534,703